Investing Ideas
/
Swedish Pharmaceuticals & Biotech Price disconnect

Swedish Pharmaceuticals & Biotech Price disconnect

Results

0 new

Stocks which the market has priced substantially different to their cash flows, which could imply risk.

4 companies

Bonesupport Holding

Market Cap: SEK 14.7b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.

BONEX

SEK 223.60

1.5%

-28.1%

Swedencare

Market Cap: SEK 3.4b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

SECARE

SEK 21.45

-2.5%

-40.3%

Cantargia

Market Cap: SEK 467.1m

A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.

CANTA

SEK 1.88

3.1%

-39.4%

Sprint Bioscience

Market Cap: SEK 369.3m

A pharmaceutical company, engages in the development of drug candidates to treat cancer in Sweden.

SPRINT

SEK 3.50

-2.8%

483.3%